Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
Author:
Funder
Novo Nordisk Fonden
Fonds Wetenschappelijk Onderzoek Vlaanderen
European Union
German Research Foundation
Publisher
Elsevier BV
Reference150 articles.
1. Global burden of alcohol use disorders and alcohol liver disease;Rehm;Biomedicines,2019
2. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis;Riazi;Lancet Gastroenterol Hepatol,2022
3. A multi-society Delphi consensus statement on new fatty liver disease nomenclature;Rinella;J Hepatol,2023
4. Mortality in biopsy-proven alcohol-related liver disease: a population-based nationwide cohort study of 3453 patients;Hagström;Gut,2021
5. Prospective study of outcomes in adults with nonalcoholic fatty liver disease;Sanyal;New Engl J Med,2021
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies;Metabolism;2024-12
2. Population screening for cirrhosis;Hepatology Communications;2024-08-26
3. Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal context;Hepatology Communications;2024-07
4. Deep Proteome Profiling of Metabolic Dysfunction-Associated Steatotic Liver Disease;2024-05-24
5. Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomy;2024-04-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3